Olaparib plus abiraterone for mCRPC: are biomarkers necessary?
The nurses’ role in improving the clinical trial experience of patients
Results of a Phase III trial on CT-P6, a trastuzumab biosimilar candidate, in early breast cancer
Phase III METEOR trial: cabozantinib vs everolimus for advanced clear cell renal cell carcinoma
Data update in advanced stage NSCLC